Eyeworld Supplements

A persuasive study found the AcrySof IQ produced significantly greater reduction in glare and in- creased the ability of drivers to execute turns more safely in low light condi- tions. 1 Simulator studies have also shown patients are able to recognize targets faster with an aspheric IOL compared to a standard or spherical IOL. 2 Being able to recognize objects better under photostress conditions (such as a significant amount of glare or a setting sun) is also improved with the AcrySof IQ. 3 That makes a big difference to patients—even when the patient is only interested in a monofocal lens, glare and imperfect lighting conditions are common complaints this lens can improve. Benefits of longevity I personally have years of experience implanting this particular lens, and that also eases patient concerns. I can point to studies that confirm how well tolerated the lens is and how long it's been commercialized in the U.S., and they find great comfort in that. From a surgical standpoint, this lens is incredibly stable in the eye, and most surgeons are familiar with the platform. I am happy to provide my monofocal cataract patients with an option that is anything but "bargain basement." The benefits of this lens have consistently been greatly appreciated by my patients— and knowing I can give them back their driving confidence in lower light- ing situations is yet another bonus. References 1. Gray R, Hill W, Neuman B, et al. Effects of a blue light-filtering intraocular lens on driving safety in glare conditions. J Cataract Refract Surg. 2012;38(5):816–22. 2. AcrySof IQ IOL Directions for Use 3. Hammond B, et al. Contralateral comparison of blue-filtering and non-blue-filtering intraocular lenses: glare disability, heterochromatic contrast, and photostress recovery. Clin Ophthalmol. 2010; 4:1465–1473. Dr. Woodard is in private practice at Omni Eye Atlanta. He can be contacted at 404-257-0814 or lwoodard@omnieyeatlanta.com. Dr. Woodard is a paid consultant for Alcon. 6 AcrySof IQ Intraocular Lenses Caution: Federal (USA) law restricts this device to the sale by or on the order of a physician. Indications: The AcrySof IQ posterior chamber intraocular lens is intended for the replacement of the human lens to achieve visual correction of aphakia in adult patients following cataract surgery. This lens is in- tended for placement in the capsular bag. Warning/precaution: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Caution should be used prior to lens encapsulation to avoid lens decentrations or dislocations. Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof Natural IOL and normal color vision. The effect on vision of the AcrySof Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve dis- eases) has not been studied. Do not resterilize; do not store over 45 degrees C; use only sterile irrigating solutions such as BSS or BSS PLUS Sterile Intraocular Irrigating Solutions. Attention: Reference the Directions for Use labeling for a complete listing of indications, warnings, and precautions. AcrySof IQ Toric Intraocular Lenses Caution: Federal (USA) law restricts this device to the sale by or on the order of a physician. Indications: The AcrySof IQ Toric posterior chamber intraocular lenses are intended for primary implantation in the capsular bag of the eye for visual correction of aphakia and pre-existing corneal astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia, who desire im- proved uncorrected distance vision, reduction of residual refractive cylinder, and increased spectacle independence for distance vision. Warning/precaution: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/bene- fit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate. Optical theory suggests that high astigmatic patients (i.e.>2.5 D) may experience spatial dis- tortions. Possible toric IOL related factors may include residual cylindrical error or axis mis- alignments. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure available from Alcon for this product informing them of possible risks and benefits associated with the AcrySof IQ Toric Cylinder Power IOLs. Studies have shown that color vision discrimi- nation is not adversely affected in individuals with the AcrySof Natural IOL and normal color vision. The effect on vision of the AcrySof Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45 degrees C; use only sterile irrigating solutions such as BSS or BSS PLUS Sterile Intraocular Irrigating Solutions. Attention: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions. Important product information © 2014 Novartis 1/15 ACR14046JS Clinical update on blue light filtering and aspheric technologies

• Cover